Preparing for 2017’s Tougher Lab Regulations and New Legal Issues: What Every Lab and Pathology Group Needs to Know to Protect Revenue and Stay Compliant
Webinar was held Wednesday,
October 16, 2016 at 1PM EDT
Tougher challenges are coming to all labs in 2017! The new year will bring significant changes to lab test reimbursement, lab compliance, and managed care contracting. Most of these challenges all boil down to one thing: tougher actions by government and private payers which everyone expects will have negative financial consequences for the nation’s medical laboratories and pathology groups.
In fact, it is now generally acknowledged that all the coming changes make 2017 a high-stakes year for the entire clinical laboratory industry and pathology profession. Take PAMA’s lab test price market reporting requirement, for example. Of course you know CMS will use that data to re-price the Part B clinical laboratory fee schedule downward, starting on January 1, 2018. But did you know that your existing managed care contracts—as currently written—probably set up your lab to take even deeper price cuts on your private payer claims in 2018!
Thus, your lab is poised to take a double–revenue hit during 2018, unless you take the right steps now to change the language in your lab’s most important managed care contracts. And that’s just one essential strategy your lab must implement in response to everything that changes in 2017.
To help all clinical laboratories and anatomic pathology groups prepare for these challenges, The Dark Report has arranged a special 90-minute webinar that features several of the nation’s most respected experts in laboratory law, regulation, and managed care contracting. On October 12, at 1 PM EDT, from the law firm McDonald Hopkins, attorneys Richard S. Cooper, Jane Pine Wood, and Elizabeth Sullivan will discuss the most important changes coming to the clinical lab and anatomic pathology marketplace in 2017.
Take advantage of your opportunity to interact directly with Cooper, Wood, and Sullivan on the key issues that will confront your lab after January 1. Based in their work with client labs, national laboratory medicine societies and associations, and their discussions with CMS, policymakers, Medicare Administrative Contracts, and managed care companies, they have invaluable insights and recommendations.
This is the webinar that can save your lab thousands of dollars in compliance costs. It is also the webinar that guides you to the right managed care contracting strategies for 2017—and that can mean hundreds of thousands of dollars in additional revenue for your clinical lab or pathology group.Take advantage of your opportunity to interact directly with Cooper, Wood, and Sullivan on the key issues that will confront your lab after January 1. Based in their work with client labs, national laboratory medicine societies and associations, and their discussions with CMS, policymakers, Medicare Administrative Contracts, and managed care companies, they have invaluable insights and recommendations.
You know all the major developments that will unfold in 2017. These include PAMA lab test market price reporting, ADLTs (definitions/pricing by Medicare), LDT regulation by the FDA, expanded lab audits by public and private payers, and more. But what you don’t know is the best responses and actions your clinical lab and pathology group can take in response to all of these major changes and unwelcome developments.
That’s why you will want to join us on October 12 for this very special 90-minute webinar. Best of all, for the same price, you can have everyone on your lab team sit in and participate. It is the opportunity for your administrative leaders, compliance managers, billing/coding/collections managers, and managed care managers to hear, first-hand, the best and worst of what will happen in 2017 with new lab regulations, changes to managed care contracts, tougher audits of labs, even developments in tougher CLIA inspections of clinical and anatomic pathology labs.
Listen and learn from the shared wisdom of our expert faculty
as they address key issues in these primary areas:
- PAMA Market Price Reporting
Most clinical laboratories and pathology groups are already behind the eight-ball in meeting the final rule’s requirements for lab test market price reporting. Get exclusive insights about the processes your lab needs to put in place right away, and in 2017
Richard S. Cooper, Attorney and Partner, McDonald Hopkins, Cleveland, OH.
Rick Cooper is the Manager of McDonald Hopkins’ National Healthcare Practice Group and is co-chair of its Healthcare Restructuring Practice Group. He focuses his national practice in healthcare law, representing clients in transactional, restructuring, corporate, compliance, regulatory, licensure, reimbursement, contractual, strategic planning, and venture matters. Practice group clients include private practice and academic physician groups, physician networks, laboratories, healthcare associations and societies, multi-specialty clinics, medical staffs, imaging centers, surgery centers, outpatient medical facilities, home health providers, hospitals and health systems (including tax-exempt and investor owned hospitals, critical access to large systems and academic medical centers), mental health/substance abuse facilities, occupational medicine companies, healthcare technology companies, and healthcare billing and management companies, and healthcare funds.
Jane Pine Wood, Chief Legal Counsel, Chief Compliance Officer, BioReference Laboratories, Inc. Elmwood Park, NJ.
Jane Pine Wood is Chief Legal Counsel and Chief Compliance Officer of BioReference Laboratories, Inc. She was previously a member of the law firm of McDonald Hopkins LLC for 28 years, where she represented clinical, anatomic, molecular and toxicology laboratories in regulatory, reimbursement and contractual matters. Ms. Wood speaks regularly on pathology and laboratory issues at national and regional conferences, and she is a frequent writer and contributor to industry publications. She received her J.D. degree in 1987 from Vanderbilt University School of Law and is admitted to practice in Massachusetts, Ohio and Tennessee.
Elizabeth Sullivan, McDonald Hopkins, Cleveland, OH.
Elizabeth A. Sullivan is a member of the McDonald Hopkins Business Department and National Healthcare Practice. Sullivan recently returned to McDonald Hopkins where she started her legal career in 2008. For the past four years, she served as associate counsel for the Cleveland Clinic Foundation where she provided regulatory advice and transactional guidance to various service lines including the clinical laboratory, professional pathology, imaging, transplant, and remote and distance health teams.
During her career, Sullivan has provided support to entities during licensure and accreditation surveys and assisted in navigating state professional licensure laws, CLIA standards and state laboratory laws, government and private payor reimbursement, fraud and abuse rules, state telehealth laws, HIPAA rules and regulations, and state and federal pharmacy regulations. Sullivan earned a J.D. from the University of Pittsburgh School of Law in 2008 where she also received a Certificate of Advanced Studies in Heath Law.